MPM BioImpact LLC — 13F holdings

MPM BioImpact LLC reported 37 holdings worth $1.64B in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. CGEM CULLINAN THERAPEUTICS INC — $177M (10.8%)
2. AKTS AKTIS ONCOLOGY INC — $156M (9.5%)
3. LQDA LIQUIDIA CORPORATION — $111M (6.7%)
4. RVMD REVOLUTION Medicines Inc — $92.2M (5.6%)
5. CORT CORCEPT THERAPEUTICS INC — $67.0M (4.1%)
6. EWTX EDGEWISE THERAPEUTICS INC — $65.9M (4.0%)
7. TVTX TRAVERE THERAPEUTICS INC — $63.8M (3.9%)
8. DBVT DBV TECHNOLOGIES S A — $60.1M (3.7%)
9. TRVI Trevi Therapeutics Inc — $57.3M (3.5%)
10. ALMS ALUMIS INC — $56.8M (3.5%)